CPHA Canvax

"This is a general guidance document that can be used as a reference for making decisions about and planning the introduction of a vaccine into a national immunization programme. It draws from the experiences of many countries that have introduced new vaccines.

This document is an update of the 2005 WHO Vaccine Introduction Guidelines and it brings together the recommendations and guidance from many recent guidelines, tools and other documents on specific aspects of immunization and on specific vaccines. It provides updated information relevant to many vaccines that are being introduced into national immunization programmes now and in the coming years, including pneumococcal conjugate, rotavirus, meningococcal A, rubella, human papillomavirus (HPV), Japanese encephalitis, and inactivated polio vaccines. For more detailed information about a specific vaccine or aspect of immunization, decision-makers and planners should consult vaccine-specific introduction guidelines and other tools developed by WHO, UNICEF and other partners. This document provides links to many of these guidelines and tools". - Principles and Considerations for Adding a Vaccine to a National Immunization Programme: From Decision to Implementation and Monitoring

Rating See Comments Ratings


Vaccine Safety and Development,Research and Development,Vaccine Technology and New Vaccines,Program Planning and Delivery,Program Delivery and Evaluation,Guides Vaccine Safety and Development
Research and Development
Vaccine Technology and New Vaccines
Program Planning and Delivery
Program Delivery and Evaluation


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.